Literature DB >> 17015228

Mechanisms of neuropathic pain.

James N Campbell1, Richard A Meyer.   

Abstract

Neuropathic pain refers to pain that originates from pathology of the nervous system. Diabetes, infection (herpes zoster), nerve compression, nerve trauma, "channelopathies," and autoimmune disease are examples of diseases that may cause neuropathic pain. The development of both animal models and newer pharmacological strategies has led to an explosion of interest in the underlying mechanisms. Neuropathic pain reflects both peripheral and central sensitization mechanisms. Abnormal signals arise not only from injured axons but also from the intact nociceptors that share the innervation territory of the injured nerve. This review focuses on how both human studies and animal models are helping to elucidate the mechanisms underlying these surprisingly common disorders. The rapid gain in knowledge about abnormal signaling promises breakthroughs in the treatment of these often debilitating disorders.

Entities:  

Mesh:

Year:  2006        PMID: 17015228      PMCID: PMC1810425          DOI: 10.1016/j.neuron.2006.09.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  133 in total

Review 1.  Central sensitization and LTP: do pain and memory share similar mechanisms?

Authors:  Ru-Rong Ji; Tatsuro Kohno; Kimberly A Moore; Clifford J Woolf
Journal:  Trends Neurosci       Date:  2003-12       Impact factor: 13.837

2.  Silas Weir Mitchell, MD: the physician who discovered causalgia.

Authors:  Frank H Lau; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2004-03       Impact factor: 2.230

3.  Key role of the dorsal root ganglion in neuropathic tactile hypersensibility.

Authors:  Inna Sukhotinsky; Efrat Ben-Dor; Pnina Raber; Marshall Devor
Journal:  Eur J Pain       Date:  2004-04       Impact factor: 3.931

4.  Myelinated afferents signal the hyperalgesia associated with nerve injury.

Authors:  James N Campbell; Srinivasa N Raja; Richard A Meyer; Susan E Mackinnon
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

5.  Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.

Authors:  Sarah J L Flatters; Gary J Bennett
Journal:  Pain       Date:  2004-05       Impact factor: 6.961

6.  Discharge pattern of afferent fibers from a neuroma.

Authors:  H Blumberg; W Jänig
Journal:  Pain       Date:  1984-12       Impact factor: 6.961

7.  Spinal nerve injury increases the percentage of cold-responsive DRG neurons.

Authors:  L Djouhri; D Wrigley; P D Thut; M S Gold
Journal:  Neuroreport       Date:  2004-03-01       Impact factor: 1.837

8.  Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat.

Authors:  Nicole Alessandri-Haber; Olayinka A Dina; Jenny J Yeh; Carlos A Parada; David B Reichling; Jon D Levine
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

Review 9.  Biochemical pharmacology of the vanilloid receptor TRPV1. An update.

Authors:  Daniel N Cortright; Arpad Szallasi
Journal:  Eur J Biochem       Date:  2004-05

10.  The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling.

Authors:  C Kleinschnitz; J Brinkhoff; M Zelenka; C Sommer; G Stoll
Journal:  J Neuroimmunol       Date:  2004-04       Impact factor: 3.478

View more
  380 in total

1.  TET1 Overexpression Mitigates Neuropathic Pain Through Rescuing the Expression of μ-Opioid Receptor and Kv1.2 in the Primary Sensory Neurons.

Authors:  Qiang Wu; Guihua Wei; Fengtao Ji; Shushan Jia; Shaogen Wu; Xinying Guo; Long He; Zhiqiang Pan; Xuerong Miao; Qingxiang Mao; Yong Yang; Minghui Cao; Yuan-Xiang Tao
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  Electrophysiological properties of spinal wide dynamic range neurons in neuropathic pain rats following spinal nerve ligation.

Authors:  Feng-Yu Liu; Xiao-Xiu Qu; Jie Cai; Fa-Tian Wang; Guo-Gang Xing; You Wan
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

3.  Predictors of outcome after surgery with disc prosthesis and rehabilitation in patients with chronic low back pain and degenerative disc: 2-year follow-up.

Authors:  Christian Hellum; Lars Gunnar Johnsen; Øyvind Gjertsen; Linda Berg; Gesche Neckelmann; Oliver Grundnes; Ivar Rossvoll; Jan Sture Skouen; Jens Ivar Brox; Kjersti Storheim
Journal:  Eur Spine J       Date:  2012-01-13       Impact factor: 3.134

Review 4.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

Review 5.  Spinal cord stimulation: neurophysiological and neurochemical mechanisms of action.

Authors:  Yun Guan
Journal:  Curr Pain Headache Rep       Date:  2012-06

6.  Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy.

Authors:  Claudia M Campbell; Mark S Kipnes; Bruce C Stouch; Kerrie L Brady; Margaret Kelly; William K Schmidt; Karin L Petersen; Michael C Rowbotham; James N Campbell
Journal:  Pain       Date:  2012-06-08       Impact factor: 6.961

Review 7.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

8.  Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury.

Authors:  Takashi Hirai; Mitsuhiro Enomoto; Hidetoshi Kaburagi; Shinichi Sotome; Kie Yoshida-Tanaka; Madoka Ukegawa; Hiroya Kuwahara; Mariko Yamamoto; Mio Tajiri; Haruka Miyata; Yukihiko Hirai; Makoto Tominaga; Kenichi Shinomiya; Hidehiro Mizusawa; Atsushi Okawa; Takanori Yokota
Journal:  Mol Ther       Date:  2013-10-28       Impact factor: 11.454

9.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

10.  Runx1 controls terminal morphology and mechanosensitivity of VGLUT3-expressing C-mechanoreceptors.

Authors:  Shan Lou; Bo Duan; Linh Vong; Bradford B Lowell; Qiufu Ma
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.